Flt3抑制通过抑制CD103+树突状细胞介导的T细胞活化减轻慢性肾脏病
本研究在阿霉素肾病(AN)小鼠模型中探讨选择性Flt3抑制剂AC220对CD103+树突状细胞(DC)及肾损伤的影响。结果显示AC220减少肾脏CD103+DC数量,改善肾功能、减轻损伤和纤维化,并降低炎症因子及T细胞浸润,其保护作用与抑制CD103+DC介导的CD8+T细胞增殖活化相关。
要点
- AC220减少AN小鼠肾脏CD103+DC数量,不减少CD103-DC或浆细胞样DC。
- AC220改善AN小鼠肾功能,减轻肾损伤和纤维化。
- AC220降低炎症因子/趋化因子水平及CD4+、CD8+T细胞浸润。
核心结论
- Flt3抑制剂AC220有效减轻AN小鼠肾损伤,提示其可能成为治疗CKD的药剂。
研究设计与样本
- 使用选择性Flt3抑制剂AC220治疗阿霉素肾病(AN)小鼠模型。
主要发现
- 与小鼠CD103+DC同源的人CD141+DC在FSGS患者中显著增加。
- AC220给药后AN小鼠肾脏CD103+DC数量显著减少,而CD103-DC或浆细胞样DC未显著减少。
- AC220治疗显著改善AN小鼠肾功能,减轻肾损伤和纤维化。
- AC220治疗降低AN小鼠炎症细胞因子和趋化因子(TNF-α、IL-1β、IL-6、CCL2、CCL5)水平,减少CD4+T细胞和CD8+T细胞肾脏浸润。
- AC220的保护作用与其抑制AN小鼠中CD103+DC介导的CD8+T细胞增殖和活化相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic kidney disease (CKD) is a global public health problem, which lacks effective treatment. Previously, we have shown that CD103+ dendritic cells (DCs) are pathogenic in adriamycin nephropathy (AN), a model of human focal segmental glomerulosclerosis (FSGS). Fms-like tyrosine kinase 3 (Flt3) is a receptor that is expressed with high specificity on tissue resident CD103+ DCs. METHODS: To test the effect on CD103+ DCs and kidney injury of inhibition of Flt3, we used a selective Flt3 inhibitor (AC220) to treat mice with AN. RESULTS: Human CD141+ DCs, homologous to murine CD103+ DCs, were significantly increased in patients with FSGS. The number of kidney CD103+ DCs, but not CD103- DCs or plasmacytoid DCs, was significantly decreased in AN mice after AC220 administration. Treatment with AC220 significantly improved kidney function and reduced kidney injury and fibrosis in AN mice. AC220-treated AN mice had decreased levels of inflammatory cytokines and chemokines, tumor necrosis factor-α, interleukin (IL)-1β, IL-6, CCL2 and CCL5 and reduced kidney infiltration of CD4 T cells and CD8 T cells. The protective effect of AC220 was associated with its suppression of CD103+ DCs-mediated CD8 T cell proliferation and activation in AN mice. CONCLUSION: Flt3 inhibitor AC220 effectively reduced kidney injury in AN mice, suggesting that this inhibitor might be a useful pharmaceutical agent to treat CKD.
引用
- Wang R, Chen T, Wang C, et al. Flt3 inhibition alleviates chronic kidney disease by suppressing CD103+ dendritic cell-mediated T cell activation. Nephrol Dial Transplant. 2019. PMID: 30590794. doi:10.1093/ndt/gfy385
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。